Suscribirse

Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes - 15/02/22

Doi : 10.1016/j.diabet.2022.101320 
Kuanrong Li a, 1, , Xiaojun Li a, 1, Abraham N. Morse b, Jiaying Fan c, Chuanzi Yang a, Chongjuan Gu c, Huishu Liu c, 1,
a Clinical Epidemiology Group, Department of Clinical Research, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China 
b Tufts University School of Medicine 
c Department of Gynecology and Obstetrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China 

Corresponding authors at: Jinsui 9, Guangzhou, 510623, ChinaJinsui 9Guangzhou510623China

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Aims

To estimate the residual risk associations between hyperglycemia and adverse pregnancy outcomes after glycemia-controlling intervention.

Methods

Among 41,067 Chinese women, those with gestational diabetes mellitus (GDM), according to the IADPSG criteria, received standard interventions to control glycemia. Risk associations of plasma glucose (PG) levels with excess newborn birth weight, primary cesarean section, and preterm delivery were estimated and compared with those in the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study, where hyperglycemia was left untreated.

Results

A total of 6,709 (16.3%) women developed GDM and thus received predominantly lifestyle interventions. The incidence of excess newborn birth weight, primary cesarean section, and preterm delivery was 6.1%, 19.1%, and 4.0%, respectively. Higher fasting and higher post-load PG levels during 75-g oral glucose tolerance test (OGTT) were statistically significantly associated with increased risks of excess newborn birth weight and pre-term delivery. Compared with the HAPO study, the association of fasting PG level with excess newborn birth weight showed similar strength and dose-response pattern, contrasting with considerably weakened associations for post-load PG levels that involved glycemic control. Contrary risk associations were seen across GDM subtypes - compared with non-GDM, isolated fasting GDM was associated with increased, whereas isolated post-load GDM was associated with decreased, risks of excess newborn birth weight and primary cesarean section. Limiting the analysis to non-GDM women and GDM women with low HbA1c (<6.0%) ≥30 days after interventions overall attenuated the risk associations.

Conclusions

Residual risk associations exist between hyperglycemia and adverse pregnancy outcomes despite seemingly appropriate glycemic control.

El texto completo de este artículo está disponible en PDF.

Keywords : Chinese women, Cohort study, Excess newborn birth weight, Gestational diabetes mellitus, Hyperglycemia, Preventive potential


Esquema


© 2022  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 48 - N° 1

Artículo 101320- janvier 2022 Regresar al número
Artículo precedente Artículo precedente
  • Type 1 diabetes mellitus and risks of major psychiatric disorders: A nationwide population-based cohort study
  • Mu-Hong Chen, Shih-Jen Tsai, Ya-Mei Bai, Kai-Lin Huang, Tung-Ping Su, Tzeng-Ji Chen, Ju-Wei Hsu
| Artículo siguiente Artículo siguiente
  • Statin use in patients with diabetes amid COVID-19 pandemic
  • Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.